News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
848,383 Results
Type
Article (86564)
Company Profile (702)
Press Release (761117)
Multimedia
Podcasts (132)
Webinars (14)
Section
Business (232714)
Career Advice (4128)
Deals (39727)
Drug Delivery (129)
Drug Development (91000)
Employer Resources (198)
FDA (18124)
Job Trends (17342)
News (396532)
Policy (39761)
Tag
Academia (3001)
Academic (2)
Accelerated approval (7)
Adcomms (30)
Allergies (96)
Alliances (56856)
ALS (107)
Alzheimer's disease (1516)
Antibody-drug conjugate (ADC) (166)
Approvals (18074)
Artificial intelligence (343)
Autoimmune disease (30)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (88)
Brain cancer (33)
Breast cancer (324)
Cancer (2549)
Cardiovascular disease (214)
Career advice (3535)
Career pathing (34)
CAR-T (186)
Cell therapy (520)
Cervical cancer (22)
Clinical research (73584)
Collaboration (954)
Company closure (2)
Compensation (597)
Complete response letters (30)
COVID-19 (2875)
CRISPR (55)
C-suite (281)
Cystic fibrosis (111)
Data (2479)
Decentralized trials (2)
Denatured (46)
Depression (57)
Diabetes (309)
Diagnostics (6942)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (156)
Drug pricing (136)
Drug shortages (33)
Duchenne muscular dystrophy (110)
Earnings (97354)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (130470)
Executive appointments (811)
FDA (19608)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (858)
Gene editing (131)
Generative AI (36)
Gene therapy (389)
GLP-1 (872)
Government (5180)
Grass and pollen (6)
Guidances (174)
Healthcare (20894)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (158)
Indications (31)
Infectious disease (3040)
Inflammatory bowel disease (159)
Inflation Reduction Act (12)
Influenza (59)
Intellectual property (106)
Interviews (813)
IPO (17851)
IRA (51)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (569)
Leadership (24)
Legal (10120)
Liver cancer (82)
Lung cancer (358)
Lymphoma (169)
Machine learning (9)
Management (65)
Manufacturing (382)
MASH (88)
Medical device (14652)
Medtech (14657)
Mergers & acquisitions (22472)
Metabolic disorders (833)
Multiple sclerosis (92)
NASH (23)
Neurodegenerative disease (126)
Neuropsychiatric disorders (36)
Neuroscience (2162)
NextGen: Class of 2025 (7682)
Non-profit (5084)
Now hiring (42)
Obesity (444)
Opinion (277)
Ovarian cancer (85)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (170)
Partnered (25)
Patents (268)
Patient recruitment (124)
Peanut (51)
People (65392)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22715)
Phase II (31961)
Phase III (24058)
Pipeline (1522)
Policy (187)
Postmarket research (3552)
Preclinical (10263)
Press Release (72)
Prostate cancer (115)
Psychedelics (38)
Radiopharmaceuticals (271)
Rare diseases (449)
Real estate (7393)
Recruiting (75)
Regulatory (26862)
Reports (61)
Research institute (2660)
Resumes & cover letters (649)
Rett syndrome (7)
RNA editing (8)
RSV (50)
Schizophrenia (84)
Series A (148)
Series B (99)
Service/supplier (30)
Sickle cell disease (61)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4295)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (59)
The Weekly (84)
Vaccines (830)
Venture capitalists (45)
Weight loss (308)
Women's health (42)
Worklife (20)
Date
Today (107)
Last 7 days (902)
Last 30 days (3713)
Last 365 days (35542)
2025 (13922)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (62)
Alaska (7)
Arizona (271)
Arkansas (14)
Asia (50213)
Australia (8843)
California (6944)
Canada (2160)
China (594)
Colorado (299)
Connecticut (316)
Delaware (173)
Europe (115255)
Florida (1012)
Georgia (235)
Hawaii (1)
Idaho (65)
Illinois (658)
India (31)
Indiana (349)
Iowa (13)
Japan (187)
Kansas (114)
Kentucky (28)
Louisiana (16)
Maine (72)
Maryland (1011)
Massachusetts (5299)
Michigan (258)
Minnesota (442)
Mississippi (2)
Missouri (93)
Montana (31)
Nebraska (26)
Nevada (73)
New Hampshire (70)
New Jersey (1933)
New Mexico (31)
New York (1942)
North Carolina (1174)
North Dakota (10)
Northern California (2992)
Ohio (231)
Oklahoma (15)
Oregon (48)
Pennsylvania (1505)
Puerto Rico (14)
Rhode Island (36)
South America (1653)
South Carolina (28)
South Dakota (1)
Southern California (2563)
Tennessee (111)
Texas (1040)
United States (26368)
Utah (203)
Virginia (183)
Washington D.C. (74)
Washington State (632)
West Virginia (3)
Wisconsin (76)
There are 848,383 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
U.S. FDA Approves BLA for Novavax’s COVID-19 Vaccine
May 19, 2025
·
9 min read
Press Releases
Armata Pharmaceuticals Announces Positive Topline Data from the Phase 1b/2a diSArm Study of Intravenously Administered AP-SA02 in Complicated Staphylococcus aureus Bacteremia
May 19, 2025
·
7 min read
Press Releases
Cristcot Appoints Jenny Gizzi as Chief Administrative Officer
May 19, 2025
·
6 min read
Press Releases
Reunion Neuroscience Announces Last Patient Dosed in RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
May 19, 2025
·
4 min read
Press Releases
Atsena Therapeutics Announces Positive Clinical Data from Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy to Treat X-linked Retinoschisis (XLRS)
May 19, 2025
·
6 min read
Press Releases
Altimmune Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder (AUD)
May 19, 2025
·
5 min read
Press Releases
Aspira Announces First Quarter 2025 Financial Results and Provides Business Update
May 19, 2025
·
8 min read
Press Releases
Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders
May 19, 2025
·
6 min read
Press Releases
Signios Bio and Illumina Announce Grant to Maximize Discovery Power with Industry’s Largest NGS-Based Proteomics Panel
May 19, 2025
·
2 min read
Press Releases
Juvena Therapeutics Announces Initiation of First-in-Human Clinical Trial of JUV-161
May 19, 2025
·
5 min read
1 of 84,839
Next
